Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,120 public trials 3,997 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)

NCT06189391

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Fifth Medical Center of PLA General Hospital ( Site 0005) Beijing, Beijing Municipality, China
  • Beijing Cancer hospital ( Site 0001) Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Xiamen University ( Site 0011) Xiameng, Fujian, China
  • Sun Yat-Sen University Cancer Center ( Site 0003) Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Recruiting

REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT07229235

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Novartis Investigative Site Alessandria, AL, Italy
  • Novartis Investigative Site Avellino, AV, Italy
  • Novartis Investigative Site Brescia, BS, Italy
  • Novartis Investigative Site Florence, FI, Italy
View Trial Details
Recruiting

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

NCT04664179

Conditions
DNA Virus Infections, EBV Related Non-Hodgkin's Lymphoma, EBV-Related Hodgkin Lymphoma, +16 more
Locations
  • Harris Health System - Ben Taub General Hospital/Smith Clinic Houston, Texas, United States
  • Houston Methodist Hospital Houston, Texas, United States
  • Texas Children's Hospital Houston, Texas, United States
  • Baylor St. Luke's Medical Center Houston, Texas, United States
View Trial Details
Recruiting

Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

NCT07453095

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • AOU SS. Antonio e Biagio e Cesare Arrigo - SCDU Ematologia Alessandria, Italy
  • Policlinico S.Orsola-Malpighi - Istituto di Ematologia Seragnoli Bologna, Italy
  • ASST Spedali Civili - Ematologia Brescia, Italy
  • Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia Florence, Italy
View all 14 locations
View Trial Details
Recruiting

Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT06544785

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • H. General Univ. de Alicante Alicante, Spain
  • H. Clínic de Barcelona Barcelona, Spain
  • H. Vall d' Hebron Barcelona, Spain
  • Hospital del Mar Barcelona, Spain
View all 19 locations
View Trial Details

Related conditions